$1.95 Billion is the total value of NEA Management Company, LLC's 57 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 7.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BHG | BRIGHT HEALTH GROUP INC | $397,146,000 | -5.7% | 218,212,126 | 0.0% | 20.40% | +67.7% | |
COUR | COURSERA INC | $225,005,000 | +574.8% | 15,867,769 | 0.0% | 11.56% | +1100.0% | |
Sell | IONQ INC | $115,413,000 | -69.1% | 26,350,067 | -10.0% | 5.93% | -45.1% | |
Buy | ARCELLX INC | $112,703,000 | +56.1% | 6,750,264 | +4.9% | 5.79% | +177.5% | |
CRSP | CRISPR THERAPEUTICS AGnamen akt | $96,624,000 | -73.6% | 1,590,002 | 0.0% | 4.96% | -53.0% | |
NET | CLOUDFLARE INC | $82,141,000 | -63.5% | 1,877,510 | 0.0% | 4.22% | -35.0% | |
MIRM | MIRUM PHARMACEUTICALS INC | $81,495,000 | -11.6% | 4,187,801 | 0.0% | 4.19% | +57.1% | |
GLUE | MONTE ROSA THERAPEUTICS INC | $74,490,000 | -31.0% | 7,703,205 | 0.0% | 3.83% | +22.6% | |
BERKSHIRE GREY INC | $55,429,000 | -49.7% | 38,226,621 | 0.0% | 2.85% | -10.5% | ||
CTIC | Buy | CTI BIOPHARMA CORP | $48,042,000 | -51.9% | 8,047,228 | +12.7% | 2.47% | -14.4% |
NKTX | Buy | NKARTA INC | $44,003,000 | +33.1% | 3,571,640 | +22.9% | 2.26% | +136.6% |
AUPH | AURINIA PHARMACEUTICALS INC | $39,897,000 | -18.8% | 3,969,834 | 0.0% | 2.05% | +44.3% | |
SVRA | SAVARA INC | $36,690,000 | +16.0% | 24,137,931 | 0.0% | 1.88% | +106.4% | |
TRVI | Buy | TREVI THERAPEUTICS INC | $31,959,000 | +86.4% | 11,373,174 | +406375.1% | 1.64% | +231.5% |
DM | DESKTOP METAL INC | $31,697,000 | -53.6% | 14,407,594 | 0.0% | 1.63% | -17.5% | |
IVA | Buy | INVENTIVA SAads | $31,599,000 | +112.7% | 5,572,953 | +329.1% | 1.62% | +278.3% |
ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCadr | $29,040,000 | -17.5% | 17,082,612 | +0.0% | 1.49% | +46.9% |
AVEO | AVEO PHARMACEUTICALS INC | $25,931,000 | +17.4% | 3,952,957 | 0.0% | 1.33% | +108.8% | |
OYST | OYSTER PT PHARMA INC | $25,656,000 | -62.8% | 5,925,287 | 0.0% | 1.32% | -33.8% | |
GERN | GERON CORP | $25,294,000 | +14.0% | 16,318,681 | 0.0% | 1.30% | +102.7% | |
BUZZFEED INC | $23,614,000 | -67.5% | 15,333,892 | 0.0% | 1.21% | -42.2% | ||
MINERVA SURGICAL INC | $23,505,000 | -42.0% | 10,001,937 | 0.0% | 1.21% | +3.2% | ||
VRNA | VERONA PHARMA PLCads | $21,405,000 | -16.0% | 5,108,563 | 0.0% | 1.10% | +49.3% | |
RYTM | RHYTHM PHARMACEUTICALS INC | $20,386,000 | -64.0% | 4,912,306 | 0.0% | 1.05% | -36.0% | |
AKUS | AKOUOS INC | $20,160,000 | -1.3% | 4,298,488 | 0.0% | 1.04% | +75.4% | |
NEXTNAV INC | $18,589,000 | -66.3% | 8,189,156 | 0.0% | 0.96% | -40.1% | ||
PANW | New | PALO ALTO NETWORKS INC | $15,389,000 | – | 32,796 | +100.0% | 0.79% | – |
VTGN | VISTAGEN THERAPEUTICS INC | $14,346,000 | -29.0% | 16,302,596 | 0.0% | 0.74% | +26.2% | |
CVRX | CVRX INC | $14,249,000 | +0.3% | 2,370,858 | 0.0% | 0.73% | +78.5% | |
CSBR | CHAMPIONS ONCOLOGY INC | $13,710,000 | -1.6% | 1,713,720 | 0.0% | 0.70% | +75.1% | |
STSA | SATSUMA PHARMACEUTICALS INC | $13,012,000 | +9.0% | 3,142,958 | 0.0% | 0.67% | +93.6% | |
RPHM | RENEO PHARMACEUTICALS INC | $12,685,000 | -9.9% | 4,786,921 | 0.0% | 0.65% | +60.6% | |
AFMD | AFFIMED NV | $12,261,000 | -36.6% | 4,426,488 | 0.0% | 0.63% | +12.7% | |
INZY | INOZYME PHARMA INC | $10,494,000 | +5.0% | 2,444,379 | 0.0% | 0.54% | +86.5% | |
MILE | METROMILE INC | $8,610,000 | -30.5% | 9,384,285 | 0.0% | 0.44% | +23.5% | |
BDTX | BLACK DIAMOND THERAPEUTICS INC | $8,487,000 | -11.2% | 3,449,845 | 0.0% | 0.44% | +58.0% | |
GLBE | GLOBAL E ONLINE LTD | $7,920,000 | -40.3% | 436,282 | 0.0% | 0.41% | +6.3% | |
New | SENTI BIOSCIENCES INC | $7,455,000 | – | 4,429,725 | +100.0% | 0.38% | – | |
OBSV | OBSEVA SA | $7,384,000 | +6.6% | 4,586,563 | 0.0% | 0.38% | +89.5% | |
BILL | BILL COM HLDGS INC | $6,904,000 | -51.5% | 66,100 | 0.0% | 0.36% | -13.6% | |
ALLK | ALLAKOS INC | $6,776,000 | -45.1% | 2,164,704 | 0.0% | 0.35% | -2.2% | |
GLYC | GLYCOMIMETICS INC | $5,434,000 | -47.6% | 9,089,041 | 0.0% | 0.28% | -6.7% | |
MEIP | MEI PHARMA INC | $5,163,000 | +0.4% | 8,533,072 | 0.0% | 0.26% | +79.1% | |
XERIS BIOPHARMA HOLDINGS INC | $5,000,000 | -39.8% | 3,246,785 | 0.0% | 0.26% | +7.1% | ||
SYBX | SYNLOGIC INC | $4,864,000 | -52.1% | 4,229,410 | 0.0% | 0.25% | -14.7% | |
Buy | AIRSPAN NETWORKS HOLDINGS INC | $4,589,000 | +2.8% | 1,534,633 | +0.0% | 0.24% | +82.9% | |
LXRX | LEXICON PHARMACEUTICALS INC | $4,431,000 | -11.0% | 2,382,286 | 0.0% | 0.23% | +58.3% | |
PHAS | PHASEBIO PHARMACEUTICALS INC | $3,986,000 | -54.5% | 6,643,702 | 0.0% | 0.20% | -19.0% | |
MRKR | MARKER THERAPEUTICS INC | $3,536,000 | -25.0% | 10,714,285 | 0.0% | 0.18% | +33.8% | |
EAR | Buy | EARGO INC | $3,399,000 | -85.8% | 4,520,849 | +0.0% | 0.18% | -74.7% |
RGLS | Sell | REGULUS THERAPEUTICS INC | $2,991,000 | -30.5% | 1,445,115 | -90.0% | 0.15% | +24.2% |
UP | WHEELS UP EXPERIENCE INC | $2,069,000 | -37.3% | 1,061,259 | 0.0% | 0.11% | +11.6% | |
IMRA | Sell | IMARA INC | $1,228,000 | -80.3% | 1,006,722 | -69.6% | 0.06% | -65.0% |
ADXN | Buy | ADDEX THERAPEUTICS LTDsponsored ads | $1,083,000 | +18.5% | 941,448 | +423.0% | 0.06% | +115.4% |
TCON | TRACON PHARMACEUTICALS INC | $693,000 | -24.0% | 346,719 | 0.0% | 0.04% | +38.5% | |
LUMO | Sell | LUMOS PHARMA INC | $503,000 | -68.1% | 65,374 | -61.0% | 0.03% | -42.2% |
AKTX | AKARI THERAPEUTICS PLCadr | $452,000 | -16.8% | 452,167 | 0.0% | 0.02% | +43.8% | |
GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -10,376,936 | -100.0% | -0.38% | – |
Exit | ROBINHOOD MKTS INC | $0 | – | -47,664,177 | -100.0% | -18.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
TREVENA INC | 31 | Q3 2021 | 3.3% |
AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
ARDELYX INC | 29 | Q3 2021 | 11.9% |
RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.